Biomarker Type: Genomic
-
Real-World Data: Importance of Monitoring KRAS Mutations in Blood
-
Longitudinal monitoring for the emergence of epidermal growth factor C797S resistance mutations in non-small cell lung cancer using blood-based droplet digital PCR
-
A Dropout-Regularized Classifier Development Approach Optimized for Precision Medicine Test Discovery from Omics
-
Rapid and sensitive detection of EGFR C797S mutations using a blood-based droplet digital PCR assay
-
Molecular Profiling of cell-free DNA and RNA in the Blood of Patients with Non-Small Cell Lung Cancer
-
Development of a Comprehensive Suite of Diagnostic Assays to detectable actionable and emerging biomarkers with evolving utility in Non-Small Cell Lung Cancer
-
Development and correlative analysis of a TMB in specimens with reference MSI and somatic variant results
-
Detection of Actionable Mutations in Liquid Biopsy Samples Using Targeted Next Generation Sequencing and Droplet Digital PCR
-
Highly Multiplexed Diagnostic Test for the Detection of Extended EGFR del19 Variants in Patients with NSCLC
-
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction